Pulse Biosciences (PLSE)

• Market cap: $1.11B
• 1 day: -3.28%
• 5 days: 5.50%
• 1 month: 10.45%
• 3 months: -2.60%
• 6 months: -14.65%
• Year to date: -7.31%
• 1 year: -19.68%
• 5 years: 62.46%
• 10 years: 295.44%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Employees: 75

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

1% more funds holding

Funds holding: 83 [Q1] → 84 (+1) [Q2]

7% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 27

0.38% less ownership

Funds ownership: 9.23% [Q1] → 8.85% (-0.38%) [Q2]

2% less capital invested

Capital invested by funds: $91.4M [Q1] → $89.9M (-$1.5M) [Q2]

84% less call options, than puts

Call options by funds: $87K | Put options by funds: $550K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $22 33% upside
• Avg. target: $22 33% upside
• High target: $22 33% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Oppenheimer Suraj Kalia

33% upside $22

Outperform Initiated

7 Jul 2025